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This issue contains several papers on pain management programmes with valuable insights and 
implications for all those working in – or referring to – pain management. They run from an audit of 
assessment and selection for an inpatient programme (Knight et al.), through a comparison of 
litigant and nonlitigant patient gains from a pain management programme (Twiddy et al.), to styles 
of emotional expression or suppression (Bowers et al.) and a demonstration of substantial reduction 
in GP visits – and reduction in associated costs – after a pain management programme. I have also 
reviewed a study on loneliness and social isolation, and important and rapidly growing area of 
research that is particularly relevant to chronic pain (Smith et al.). 
Few teams publicly dissect their data on selection for pain management of any kind, as Knight et al. 
have done. This is a model of scrutiny of practice with a view to  Of 200 consecutive patients, just 
over half were offered treatment of some sort after assessment, while 45% were discharged. The 
most common reason for exclusion was that the patient was judged not ready for pain management, 
although this did not necessarily exclude her or him for ever. It would be interesting to know how 
many subsequently returned after, for instance, treatment of a more pressing psychological 
problem, or completing a planned course of medical treatment for pain, but that is another study. 
The authors comment that a substantial number of patients at assessment were still seeking pain 
reduction, and therefore were not willing to consider pain management, but this raises questions of 
their referral pathway and preparation (if any) for the shift of focus from pain to overall quality of 
life. These are difficult to characterise, and details are not given. The authors also check that they 
are not inadvertently discriminating on grounds of age, sex, and ethnicity, something that all pain 
clinics should do routinely. They do ask a question at the end about possible under-referral of older 
adults, among whom chronic pain is most prevalent. 
It might be useful to examine the clinician judgements of ‘readiness for pain management’ further, 
for variance between assessors, by referral origin, and possibly other variables, but ultimately we do 
not have the answer to why some patients are able to take on pain management, or even to declare 
their ambivalence but willingness to try, whereas others seem determined to continue to seek pain 
relief, despite attempts at explanation by referrers and pain management programme staff. Is there 
a desirable level of acceptance for pain management by staff (the Clare et al. study records 35% of 
referred patients completing pain management), below which staff should query their judgements 
or procedures? A strong line would be that patients decline if the explanation of pain management is 
not sufficiently persuasive or matched to their needs, but that would be to deny patients agency. A 
study of patients’ and doctors’ accounts of first consultation at a pain clinic showed worrying 
mismatch on their beliefs about of the long term plan for pain (White et al. 2016). Is pain 
management framed as the only resort after all else fails, a consolation prize for sticking with the 
health service? Or as an evidence-based approach to addressing the wider problems of living with 
chronic pain, and one which might (again, referring to systematic review evidence) bring about some 
reduction in pain? Does that framing make a difference to patients’ decisions?  
Another judgement that is often enacted at assessment and selection is that patients with ongoing 
litigation are unsuitable for pain management, but Twiddy et al. show in a large sample (over 850 
patients, 110 of whom were litigating) that although their scores were worse than non-litigants at 
the outset of pain management, their gains were comparable to those of non-litigants over the 
course of treatment. The authors also calculated this in terms of clinically significant change, 
showing that from 30-80% (depending on which outcome) in both litigant and non-litigant groups 
achieved clinically significant improvement. They covaried age, sex, and pain duration in their 
analyses, important not least because litigants were more likely to be young and male than non-
litigants. They also pick up possible confounding of employment status with litigation in other 
studies. Given the consistency of their results, and support from the research literature, they declare 
that litigation should not be grounds for excluding patients from or delaying pain management, and 
while they are not the first study to find this, as they make clear, there is substantial clinician 
prejudice to overcome that needs just such studies to challenge it.  
One of the main aims of a pain management programme, but surprisingly rarely assessed, is to 
enable patient-graduates to manage their health needs more independently. The study by Clare et 
al. of GP consultations for pain in the year before and after a pain management programme shows 
over 40% reduction in median and in overall appointments across 50 patients whose records were 
obtained from GPs, with a saving of over £6000. The same team has previously shown a much larger 
reduction in specialist consultations following pain management, and their review and interpretation 
of the literature shows a thorough grasp of the issues and methodologies. It is essential reading for 
anyone considering a similar study, or could be presented to commissioners in support of the value 
of programmes, provided that they match the substantial improvements achieved on almost all 
outcomes in this pain management programme.  
By contrast, a study of fibromyalgia patients treated in five different programmes in the UK (Bowers 
et al.) showed small and nonsignificant changes except in overall quality of life, and such substantial 
dropout from the original sample that any conclusions must be fairly tentative. The research 
question is a fairly novel one: on emotion regulation and expression of emotion, and changes over 
12 weeks of pain management programme. It is an area about which we know relatively little: there 
is unlikely to be one ‘right’ way or ‘right’ amount of emotional expression across individuals, and 
even within individuals across different situations and emotions. Further, people’s accounts of how 
they express themselves and how often they show particular behaviours are notoriously 
uncorrelated with accounts by observers or close others of the same behaviours: we do not have the 
scales we require, and constructing good ones will be very difficult, but older ones such as 
alexithymia scales unacceptably incorporate cultural and class norms. All these difficulties in 
formulating the research question, and finding the right tools to answer it, will need to be addressed 
to define what better adaptation is, recognising that it could be in different directions for different 
groups, even for men and women.  
In this light, the study in this issue of social isolation and loneliness is particularly relevant (Smith et 
al.). In a representative (non-institutionalised) sample of more than 9000 over-50s, there are marked 
sex differences: women were less socially isolated (in terms of network size) but more lonely (in 
terms of feeling left out and alone) than men, but the adverse mental and physical effects – even 
mortality - of both social isolation and loneliness are possibly greater for men (Holwerda et al. 2016). 
Social activity in terms of community participation has even emerged as a protective factor against 
the development of chronic pain, along with vigorous but not moderate physical activity (Fancourt & 
Steptoe 2018), in a 10 year prospective study of people who were at the outset pain free and in their 
50s. 
Surprisingly, musculoskeletal pain (represented in the survey by a yes/no question that does not 
identify chronicity) was associated with less social isolation, perhaps (the authors suggest) because 
of formal and informal carers, but with more loneliness. Depression was associated far more 
strongly with loneliness: a fivefold difference. Older age, lower socioeconomic status, and more 
sedentary habits/less physical activity were also associated with greater loneliness. It is very helpful 
to understand that for people with chronic pain, increasing social network size may be important, 
particularly when the patient identifies it as a goal, but loneliness may be more important and is not 
a function of social network but a cognitive bias in representing the social contacts the person has 
(Cacioppo et al. 2015; Shankar et al. 2017).  
All this gives us material to consider not only in pain management but more broadly in our contact 
with people with chronic pain at all stages of their treatment. The papers discussed above mostly 
concern pain management programmes, but the issues raised apply from the start of pain 
treatment. Are we raising issues of managing daily life even when we still have a stack of 
medications and other interventions to try? Are we making fair and evidence-based decisions when 
we refer patients for pain management programmes, or assess them for such programmes? Are we 
recognising when anxieties or depressed mood are important factors beyond pain intensity in 
making life harder, and not leaving it to be addressed after everything else? Are we recognising 
loneliness, and social isolation, when we see them, and discussing with the patient what might be 
done? There is plenty to do to integrate care of pain better, and these studies all make a real 
contribution to understanding the landscape of good quality care in the UK.  
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